• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒙氏肠球菌的一种IIa类肽可抑制与中耳炎相关的细菌。

A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media.

作者信息

Knoetze H, Todorov S D, Dicks L M T

机构信息

Department of Microbiology, University of Stellenbosch, Stellenbosch 7600, South Africa.

出版信息

Int J Antimicrob Agents. 2008 Mar;31(3):228-34. doi: 10.1016/j.ijantimicag.2007.10.010. Epub 2007 Dec 26.

DOI:10.1016/j.ijantimicag.2007.10.010
PMID:18155886
Abstract

Peptide ST4SA, produced by Enterococcus mundtii ST4SA, inhibits the growth of Acinetobacter baumannii, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, Streptococcus pneumoniae and Gram-positive bacteria isolated from patients diagnosed with middle ear infections. The peptide adsorbed at a level of 94% to S. pneumoniae 40, Pseudomonas aeruginosa 25 and E. faecium HKLHS. Low concentrations of peptide ST4SA (51200 arbitrary units (AU)/mL) caused DNA and enzyme leakage from target cells, whilst 1638400AU/mL caused cell lysis. No decrease in antimicrobial activity was observed when tested on solid medium with human blood as base. Peptide ST4SA revealed a similar level of activity compared with tetracycline (30 microg), but much higher activity compared with nasal sprays, aminoglycosides, cephalosporins, fluoroquinolones, lincosamides, macrolides, nitroimidazole, penicillin, quinolones, sulphonamides, chloramphenicol, furazolidone, fusidic acid, rifampicin, trimethoprim, trimethoprim/sulfamethoxazole and vancomycin when tested in vitro. Peptide ST4SA dissipates the proton-motive force and may be used in the treatment of multidrug-resistant strains where antibiotics are excluded from cells by efflux pumps dependent on the membrane proton gradient.

摘要

蒙氏肠球菌ST4SA产生的肽ST4SA可抑制鲍曼不动杆菌、粪肠球菌、屎肠球菌、金黄色葡萄球菌、肺炎链球菌以及从诊断为中耳感染的患者中分离出的革兰氏阳性菌的生长。该肽对肺炎链球菌40、铜绿假单胞菌25和屎肠球菌HKLHS的吸附水平为94%。低浓度的肽ST4SA(51200任意单位(AU)/mL)会导致靶细胞的DNA和酶泄漏,而1638400AU/mL会导致细胞裂解。以人血为基础在固体培养基上进行测试时,未观察到抗菌活性降低。与四环素(30微克)相比,肽ST4SA显示出相似的活性水平,但在体外测试时,与鼻喷雾剂、氨基糖苷类、头孢菌素类、氟喹诺酮类、林可酰胺类、大环内酯类、硝基咪唑类、青霉素类、喹诺酮类、磺胺类、氯霉素、呋喃唑酮、夫西地酸、利福平、甲氧苄啶、甲氧苄啶/磺胺甲恶唑和万古霉素相比,其活性要高得多。肽ST4SA可消耗质子动力,可用于治疗多药耐药菌株,在这些菌株中,抗生素通过依赖膜质子梯度的外排泵被排出细胞。

相似文献

1
A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media.蒙氏肠球菌的一种IIa类肽可抑制与中耳炎相关的细菌。
Int J Antimicrob Agents. 2008 Mar;31(3):228-34. doi: 10.1016/j.ijantimicag.2007.10.010. Epub 2007 Dec 26.
2
An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans.从大豆中分离出的蒙氏肠球菌ST4V产生的一种抗菌抗病毒肽。
Int J Antimicrob Agents. 2005 Jun;25(6):508-13. doi: 10.1016/j.ijantimicag.2005.02.005.
3
Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).替加环素及对照药物对在欧洲进行的TEST研究(2004 - 2007年)中收集的细菌分离株的抗菌药敏性。
Int J Antimicrob Agents. 2009 Aug;34(2):121-30. doi: 10.1016/j.ijantimicag.2009.02.003. Epub 2009 Apr 1.
4
Survival and adherence of antimicrobial peptide ST4SA, produced by Enterococcus mundtii, at conditions found in the human gastro-intestinal tract.耐万古霉素肠球菌产生的抗菌肽 ST4SA 在人体胃肠道中发现的条件下的生存和黏附情况。
J Basic Microbiol. 2010 Dec;50 Suppl 1:S25-9. doi: 10.1002/jobm.201000249.
5
Effect of modified MRS medium on production and purification of antimicrobial peptide ST4SA produced by Enterococcus mundtii.改良MRS培养基对蒙氏肠球菌产生的抗菌肽ST4SA生产及纯化的影响
Anaerobe. 2009 Jun;15(3):65-73. doi: 10.1016/j.anaerobe.2008.11.002. Epub 2008 Dec 7.
6
Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.新型抗菌肽CECT7121对难治性严重感染患者革兰氏阳性菌的体外疗效评估。
Chemotherapy. 2009;55(4):270-7. doi: 10.1159/000223069. Epub 2009 Jun 2.
7
Characterization of a 3944 Da bacteriocin, produced by Enterococcus mundtii ST15, with activity against Gram-positive and Gram-negative bacteria.蒙氏肠球菌ST15产生的一种分子量为3944道尔顿、对革兰氏阳性菌和革兰氏阴性菌均有活性的细菌素的特性分析。
Int J Food Microbiol. 2005 Dec 15;105(3):433-44. doi: 10.1016/j.ijfoodmicro.2005.03.021. Epub 2005 Aug 15.
8
Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).作为替加环素评估与监测试验(TEST)的一部分,替加环素与其他抗菌药物对从亚太地区收集的革兰氏阴性菌和革兰氏阳性菌的体外活性比较。
Int J Antimicrob Agents. 2009 Feb;33(2):130-6. doi: 10.1016/j.ijantimicag.2008.07.031. Epub 2008 Nov 7.
9
The spectrum of antimicrobial activity of the bacteriocin subtilosin A.枯草芽孢杆菌素A的抗菌活性谱
J Antimicrob Chemother. 2007 Feb;59(2):297-300. doi: 10.1093/jac/dkl495. Epub 2007 Jan 9.
10
Antibacterial activity of seed proteins of Robinia pseudoacacia.刺槐种子蛋白的抗菌活性
Fitoterapia. 2005 Jan;76(1):67-72. doi: 10.1016/j.fitote.2004.10.020.

引用本文的文献

1
Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins.乳酸菌细菌素作用模式和免疫机制的当前知识
Microorganisms. 2021 Oct 7;9(10):2107. doi: 10.3390/microorganisms9102107.
2
Migration of Bacteriocins Across Gastrointestinal Epithelial and Vascular Endothelial Cells, as Determined Using In Vitro Simulations.采用体外模拟方法研究细菌素穿过胃肠道上皮细胞和血管内皮细胞的迁移情况。
Sci Rep. 2019 Aug 7;9(1):11481. doi: 10.1038/s41598-019-47843-9.
3
A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?
综述:细菌素在人体胃肠道中的命运:它们能穿过肠-血屏障吗?
Front Microbiol. 2018 Sep 28;9:2297. doi: 10.3389/fmicb.2018.02297. eCollection 2018.
4
Otitis Media: A Review, with a Focus on Alternative Treatments.中耳炎:一篇综述,重点关注替代疗法
Probiotics Antimicrob Proteins. 2009 Jun;1(1):45-59. doi: 10.1007/s12602-009-9008-9. Epub 2009 Mar 4.
5
Release of Enterococcus mundtii Bacteriocin ST4SA from Self-Setting Brushite Bone Cement.自固化磷酸二钙骨水泥中蒙氏肠球菌细菌素ST4SA的释放
Probiotics Antimicrob Proteins. 2011 Jun;3(2):119-24. doi: 10.1007/s12602-011-9074-7.
6
Anti-infective properties of bacteriocins: an update.细菌素的抗感染特性:更新。
Cell Mol Life Sci. 2013 Aug;70(16):2947-67. doi: 10.1007/s00018-012-1202-3. Epub 2012 Oct 30.
7
Innate immunity and the role of defensins in otitis media.先天免疫与防御素在中耳炎中的作用。
Curr Allergy Asthma Rep. 2011 Dec;11(6):499-507. doi: 10.1007/s11882-011-0223-6.
8
Release of bacteriocins from nanofibers prepared with combinations of poly(d,l-lactide) (PDLLA) and poly(ethylene oxide) (PEO).从由聚(d,l-丙交酯)(PDLLA)和聚环氧乙烷(PEO)组合制备的纳米纤维中释放细菌素。
Int J Mol Sci. 2011;12(4):2158-73. doi: 10.3390/ijms12042158. Epub 2011 Mar 29.
9
Antimicrobial compounds produced by Lactobacillus sakei subsp. sakei 2a, a bacteriocinogenic strain isolated from a Brazilian meat product.由从巴西肉类产品中分离出的具有细菌素生成特性的乳杆菌 sakei 亚种 sakei 2a 产生的抗菌化合物。
J Ind Microbiol Biotechnol. 2010 Apr;37(4):381-90. doi: 10.1007/s10295-009-0684-y.
10
In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.重组双歧杆菌素 V41 及其结构变异体对单核细胞增生李斯特菌的体内活性。
Antimicrob Agents Chemother. 2010 Jan;54(1):563-4. doi: 10.1128/AAC.00765-09. Epub 2009 Oct 19.